CD109, a new marker for myoepithelial cells of mammary, salivary, and lacrimal glands and prostate basal cells

Masaki Hasegawa, Sumitaka Hagiwara, Tomoko Sato, Mayumi Jijiwa, Yoshiki Murakumo, Masahiro Maeda, Suzuko Moritani, Shu Ichihara, Masahide Takahashi

研究成果: Article査読

36 被引用数 (Scopus)

抄録

The CD109 gene encodes a glycosylphosphatidylinositol (GPI)-anchored cell surface protein. Herein it is shown that CD109 is highly expressed in myoepithelial cells of mammary, salivary, and lacrimal glands; and in prostate basal cells. The anti-CD109 antibody generated by the authors was available for formalin-fixed paraffin section, and it strongly stained myoepithelial cells and basal cells but not ductal, acinar, and secretory cells in these glands. CD109 expression was negative in examined breast ductal carcinomas and prostate adenocarcinomas. These findings indicate that CD109 is a useful marker for the diagnosis of invasive breast and prostate carcinomas.

本文言語English
ページ(範囲)245-250
ページ数6
ジャーナルPathology International
57
5
DOI
出版ステータスPublished - 05-2007
外部発表はい

All Science Journal Classification (ASJC) codes

  • 病理学および法医学

フィンガープリント

「CD109, a new marker for myoepithelial cells of mammary, salivary, and lacrimal glands and prostate basal cells」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル